Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eat Weight Disord ; 25(5): 1243-1251, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31399910

RESUMEN

PURPOSE: The separate effects of whole grain (WG) and fruit and vegetable (F&V) diets on inflammatory biomarkers have not been assessed. Therefore, we evaluated these two high-fiber diets in relation to inflammation indices in obese and overweight women. STUDY DESIGN: Parallel randomized clinical trial. METHODS: In the present study, 75 women were recruited and randomly assigned to three diet groups: a whole grain diet (WG-D) group, F&V group, and a combined whole grain and F&V diet group (WGFV-D) for 10 weeks. As a "feeding trial" all participants were asked to visit the clinic daily and eat prescribed foods in the presence of a nutritionist. Anthropometric indices and biochemical biomarkers were measured at baseline and after 10 weeks of the trial. RESULTS: Each of the three diet groups showed significant changes in serum biomarkers (CRP, TNF-α, IL-6, D-dimer, and serum fibrinogen) after following the diet for 10 weeks (P = 0.01). In adjusted models, significant changes were observed for CRP, TNF-α, IL-6, D-dimer, and serum fibrinogen (P = 0.01). In a model adjusted for malondialdehyde (MDA) level, a trend toward significance was observed (P = 0.05). Consumption of all three different diets for 10 weeks showed statistically significant change for all biomarkers (P < 0.05) the most notable changes in inflammatory indices were observed among participants following the WG diet. CONCLUSIONS: Study results indicate that consumption of high-fiber diets, especially the WG diet, can help lower inflammatory levels and prevent subsequent adverse health consequences. LEVEL OF EVIDENCE: Level I, randomized controlled trial.


Asunto(s)
Verduras , Granos Enteros , Biomarcadores , Dieta , Femenino , Frutas , Humanos , Obesidad , Sobrepeso
2.
Stud Health Technol Inform ; 316: 998-1002, 2024 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-39176959

RESUMEN

Generative AI models, such as ChatGPT, have significantly impacted healthcare through the strategic use of prompts to enhance precision, relevance, and ethical standards. This perspective explores the application of prompt engineering to tailor outputs specifically for healthcare stakeholders: patients, providers, policymakers, and researchers. A nine-stage process for prompt engineering in healthcare is proposed, encompassing identifying applications, understanding stakeholder needs, designing tailored prompts, iterative testing and refinement, ethical considerations, collaborative feedback, documentation, training, and continuous updates. A literature review focused on "Generative AI" or "ChatGPT," prompts, and healthcare informed this study, identifying key prompts through qualitative analysis and expert input. This systematic approach ensures that AI-generated prompts align with stakeholder requirements, offering valuable insights into symptoms, treatments, and prevention, thereby supporting informed decision-making among patients.


Asunto(s)
Inteligencia Artificial , Humanos , Atención a la Salud
3.
Diabetes Metab Syndr ; 16(1): 102372, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34998259

RESUMEN

BACKGROUND AND AIMS: Due to inconsistent data about WP supplementation on inflammatory markers, present systematic review and meta-analysis was done to summarize its effect on TNF-α and IL-6. METHODS: Our search was done in Pubmed, Scopus, Embase, and Cochrane up to June 2021. Weighted mean difference (WMD) and 95% confidence intervals (CI) was used to indicate the effect sizes. Conceivable sources of heterogeneity were detected by subgroup analysis. RESULTS: Overall, 11 eligible RCTs were included. The pooled results showed that WP supplementation had no significant effect on TNF-α and IL-6 status compare to those receiving carbohydrate and other types of proteins as placebo. Results from subgroup analysis based on health status, study duration, WP dosage and sex, expressed no favorable effect of WP on TNF-α and IL-6 levels. CONCLUSION: It can be concluded that whey supplementation had no favorable effects on inflammatory biomarkers including TNF- α and IL-6.


Asunto(s)
Interleucina-6 , Factor de Necrosis Tumoral alfa , Biomarcadores/metabolismo , Suplementos Dietéticos , Humanos , Inflamación/metabolismo , Ensayos Clínicos Controlados Aleatorios como Asunto , Suero Lácteo/metabolismo , Proteína de Suero de Leche
4.
World J Pediatr ; 18(5): 320-332, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35106700

RESUMEN

BACKGROUND: Probiotic supplementation has been used to alleviate abdominal pain in children and adolescents with irritable bowel syndrome (IBS), but the evidence is not compelling. Thus, a systematic review and meta-analysis of randomized clinical trials (RCTs) were performed to investigate the effects of probiotic supplementation on abdominal pain in pediatric patients with IBS. METHODS: PubMed/MEDLINE, Web of Science, Scopus, Cochrane Library, and Embase were the available databases searched to find relevant randomized clinical trials up to April 2021. The effect size was expressed as weighted mean difference (WMD) and 95% confidence interval (CI). RESULTS: Seven RCTs with 441 participants were included, from which the meta-analysis demonstrated that probiotic supplementation has a significant effect on reducing abdominal pain in pediatric patients with IBS (WMD = - 2.36; 95% CI - 4.12 to - 0.60; P = 0.009). Although our study involved children and adolescents (≤ 18 years), the effects of probiotic supplementation seem to be more potent in patients under 10 years old (WMD = - 2.55; 95% CI - 2.84 to - 2.27) compared to patients aged 10-18 years (WMD = - 1.70; 95% CI - 2.18 to - 1.22). The length of supplementation longer than four weeks was more effective (WMD = - 2.43; 95% CI - 2.76 to - 2.09). CONCLUSION: Probiotic supplementation can reduce abdominal pain in pediatric patients with IBS.


Asunto(s)
Síndrome del Colon Irritable , Probióticos , Dolor Abdominal/tratamiento farmacológico , Dolor Abdominal/etiología , Adolescente , Niño , Humanos , Síndrome del Colon Irritable/complicaciones , Síndrome del Colon Irritable/terapia , Dimensión del Dolor , Probióticos/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA